Networking that fueled COVID-19 response should spill into digital sciences and more, says Genmab’s van de Winkel: a BioCentury audio interview

Jan van de Winkel sees a strong future for data sharing and more master protocol trials, fueled by increasing adoption of digital sciences, as companies turn the collaboration they’ve shown in COVID-19 into longer-term productive networks.

Van de Winkel, president and CEO of  Genmab A/S (CSE:GMAB; NASDAQ:GMAB), spoke to BioCentury as part of the Back to School 2020 series of audio interviews with key industry leaders (see Cover Story:  “The Imperative of COVID-19”)...